Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation

Royal Brisbane Hospital, Brisbane, Queensland, Australia
Blood (Impact Factor: 10.45). 11/2006; 108(7):2485-92. DOI: 10.1182/blood-2006-04-016063
Source: PubMed


Host antigen-presenting cells (APCs) are known to be critical for the induction of graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT), but the relative contribution of specific APC subsets remains unclear. We have studied the role of host B cells in GVHD by using B-cell-deficient microMT mice as BMT recipients in a model of CD4-dependent GVHD to major histocompatibility complex antigens. We demonstrate that acute GVHD is initially augmented in microMT recipients relative to wild-type recipients (mortality: 85% vs 44%, P < .01), and this is the result of an increase in donor T-cell proliferation, expansion, and inflammatory cytokine production early after BMT. Recipient B cells were depleted 28-fold at the time of BMT by total body irradiation (TBI) administered 24 hours earlier, and we demonstrate that TBI rapidly induces sustained interleukin-10 (IL-10) generation from B cells but not dendritic cells (DCs) or other cellular populations within the spleen. Finally, recipient mice in which B cells are unable to produce IL-10 due to homologous gene deletion develop more severe acute GVHD than recipient mice in which B cells are wild type. Thus, the induction of IL-10 in host B cells during conditioning attenuates experimental acute GVHD.

Download full-text


Available from: Kelli P A Macdonald
  • Source
    • "As previously stated B cells are also able to function as APCs and given the regulatory action of B10 cells in autoimmunity and cancer, their involvement in graft versus host disease has been hypothesized and explored. Rowe and colleagues demonstrated that B cell-deficient μMT mice receiving BM transplantation demonstrated higher mortality rates due to acute GVHD than wild type recipients (76). This seems to be directly linked to the ability of B cells acting as APCs in reducing the proliferation of CD4+ T cells as well as the production of pro-inflammatory cytokines within the donor. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Reproductive immunology research has long focused on T cell responses to paternal antigens and tolerance mechanisms supporting fetal well-being. The participation of B cells herein was not widely studied. Because of the fascinating immunological uniqueness of pregnancy it is however to be expected that such pleiotropic cells play a considerable role. In fact, on the one hand B cells contribute towards pregnancy tolerance by secreting the immunomodulatory cytokine IL-10 but on the other hand can seriously harm pregnancy because of their capacity of producing autoantibodies. As for protective B cells, new evidences in mouse models arise suggesting that IL-10 producing B cells, the so called B10 cells, help in maintaining tolerance towards semiallogenic fetal antigens. They may be also important to fight danger signals at the fetal- maternal as e.g. in the case of infections with the aim to restore the disrupted fetal tolerance. In human pregnancies, IL-10 producing B cells increase with pregnancy onset but not in the case of spontaneous abortions. In vitro, they are able to suppress TNF-α production by T cells from pregnant individuals. Their generation and functionality will be discussed throughout this review article. B cells can be deleterious to pregnancy as well. Aberrant B cell compartment is associated with obstetric pathologies. In particular the capacity of B2 cells to produce specific autoantibodies or of B1aB cells to secrete natural autoantibodies that can turn autoreactive will be discussed herein.
    Full-text · Article · Jun 2014 · Frontiers in Immunology
  • Source
    • "After infection, mice were monitored for 14 days to determine overall survival. The severity of systemic infection was examined daily using a scoring system adopted from a Graft-versus-Host disease model (Rowe et al., 2006; Weber et al., 2013) including 5 clinical parameters: weight loss, posture, activity, fur texture, and skin integrity. Mice with severe symptoms determined by clinical scores equal or greater than 6, were immediately euthanized by CO 2 , as required by the institutional animal ethics guide lines and the day subsequent to death determined as the following day. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Polymorphonuclear neutrophils (PMN) are important for the control of invasive aspergillosis (IA), a major threat to immunocompromised individuals. For clearance of Aspergillus fumigatus infections, PMN employ their potent oxidative and non-oxidative mechanisms. To clarify the relative contribution of these mechanisms, we analyzed p47(phox-/-), gp91(phox-/-) and elastase (ELA) deficient mice (ELANE) after intratracheal infection with A. fumigatus. Infected p47(phox-/-) and gp91(phox-/-) mice died within 4 days and had a significant higher fungal burden in the lungs compared to wild-type controls. Interestingly, the survival of ELANE mice after infection was unimpaired suggesting that ELA is not essential here. Nevertheless, A. fumigatus clearance was delayed in ELANE mice indicating a partial contribution of ELA to fungal immunity. Comparing p47(phox-/-), gp91(phox-/-) or ELANE mice for PMN activation and recruitment to the lungs, we were unable to detect significant differences in vitro or in vivo among mutant or wild-type strains suggesting intact PMN functionality of basic effector mechanisms. Fungal killing in vitro by ELA deficient PMN was comparably reduced as in p47(phox-/-) and gp91(phox-/-) deficient PMN corroborating the importance of oxidative and non-oxidative PMN mechanisms for the control of fungal outgrowth. Taken together, this suggests that intact oxidative as well as non-oxidative PMN effector functions are highly relevant for the control of A. fumigatus infections in vitro and in vivo. While ELA contributes to clearance of A. fumigatus, the oxidative functions are essential for survival.
    Full-text · Article · Aug 2013 · Immunobiology
  • Source
    • "The degree of systemic GvHD was examined at least every other day using a scoring system as described elsewhere [28]. The scoring system includes 5 clinical parameters: weight loss, posture, activity, fur texture, and skin integrity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Graft-versus-host disease (GvHD) is a key contributor to the morbidity and mortality after allogeneic hematopoetic stem cell transplantation (HSCT). Regulatory Foxp3 + CD4 + T cells (T reg) suppress conventional T cell activation and can control GvHD. In our previous work, we demonstrate that a basic mechanism of T reg mediated suppression occurs by the transfer of cyclic adenosine monophosphate (cAMP) to responder cells. Whether this mechanism is relevant for T reg mediated suppression of GvHD is currently unknown. To address this question, bone marrow and T cells from C57BL/6 mice were transferred into lethally irradiated BALB/c recipients, and the course of GvHD and survival were monitored. Transplanted recipients developed severe GvHD that was strongly ameliorated by the transfer of donor T reg cells. Towards the underlying mechanisms, in vitro studies revealed that T reg communicated with DCs via gap junctions, resulting in functional inactivation of DC by a metabolic pathway involving cAMP that is modulated by the phosphodiesterase (PDE) 4 inhibitor rolipram. PDE2 or PDE3 inhibitors as well as rolipram suppressed allogeneic T cell activation, indirectly by enhancing T reg mediated suppression of DC activation and directly by inhibiting responder T cell proliferation. In line with this, we observed a cooperative suppression of GvHD upon T reg transfer and additional rolipram treatment. In conclusion, we propose that an important pathway of T reg mediated control of GvHD is based on a cAMP dependent mechanism. These data provide the basis for future concepts to manipulate allogeneic T cell responses to prevent GvHD.
    Full-text · Article · Mar 2013 · PLoS ONE
Show more